ascopubs.org

31-Gene Expression Profile Testing in Cutaneous Melanoma and Survival Outcomes in a Population-Based Analysis: A SEER Collaboration

Clinical Validation of Plasma-Based Genotyping for RAS and BRAF V600E Mutation in Metastatic Colorectal Cancer: SCRUM-Japan GOZILA Substudy Patients with stage I-III CM with a clinical 31-GEP result ...
ascopubs.org

Time Series Prediction of Lung Cancer Death Rates on the Basis of SEER Data

Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in Hematology Three models for yearly time series predictions were built: autoregressive integrated ...
GEN

Seer Showcases Deep Proteomics Capabilities, Announces Co-Marketing Deal with Thermo Fisher Scientific

At ASHG, Seer showcased its Proteograph product suite which it claims delivers proteomic insights that complement and strengthen other forms of omics data. Through various sessions at the meeting, the ...
The American Journal of Managed Care

Study Finds Declining SCLC Incidence, but Stagnant Survival Rates

SCLC incidence decreased by 3% annually from 2000 to 2020, attributed to reduced smoking rates and smoking-related policies. Survival rates for SCLC have shown only minor improvements despite ...
BMJ Open

Subsequent risk of non-keratinocyte skin cancers in adult cancer survivors: a SEER-based cohort study

Objective To characterise the risk of subsequent primary non-keratinocyte skin cancers (NKSCs) among adult-onset cancer survivors. Design Data analysis of this population-based cohort study was ...
Nasdaq

Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery

Study led by Weill Cornell Medicine demonstrates identification of protein altering variants for population-scale protein quantitative trait loci (pQTL) studies Proteograph Product Suite enables ...